05 August 2021: Database Analysis
N6-Methyladenosine Regulators Are Involved in the Progression of and Have Clinical Impact on Breast Cancer
Yanni Song 12BCEFG , Chaojing Zheng 3C , Yangbao Tao 3D , Rui Huang 3E , Qian Zhang 4AE*DOI: 10.12659/MSM.929615
Med Sci Monit 2021; 27:e929615
Figure 1 RNA expression and clinicopathological characteristics. (A) Heatmap of m6A regulators expression in patients with different tumor stages and significance. (B) EIF3 RNA expression in patients with stages I, II, and III. (C) RBM15B RNA expression in patients with stages I, II, and III. (D) Heatmap of m6A regulators expression in patients of different Nottingham prognostic index (NPI). (E) EIF3 RNA expression in patients with different NPI. (F) IGF2BP3 RNA expression patients with different NPI. (G) Heatmap of m6A regulators expression in patients of different cellularity. (H) EIF3 RNA expression in patients of different cellularity. (I) RBM15 RNA expression patients of different cellularity. * P<0.5, ** P<0.01, *** P<0.001.